Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-12-01T06:50:36.918Z Has data issue: false hasContentIssue false
  • English
  • Français

Vancomycin Use in Pediatric Hematology-Oncology Patients

Published online by Cambridge University Press:  02 January 2015

Heidi A. Hopkins ,
Ronda L. Sinkowitz-Cochran ,
Benjamin A. Rudin ,
Harry L. Keyserling  and
William R. Jarvis
Heidi A. Hopkins
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Emory University, Atlanta, Georgia
Ronda L. Sinkowitz-Cochran*
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Emory University, Atlanta, Georgia
Benjamin A. Rudin
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Emory University, Atlanta, Georgia
Harry L. Keyserling
Affiliation:
Egleston Children's Hospital, Emory University, Atlanta, Georgia
William R. Jarvis
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Emory University, Atlanta, Georgia
*
Hospital Infections Program, Mailstop E-69, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333
Get access Rights & Permissions [Opens in a new window]

Abstract

A cross-sectional study was performed of pediatric hematology-oncology patients who received vancomycin; use was compared to the Centers for Disease Control and Prevention (CDC) recommendations for vancomycin use. Thirty-seven patients received 308 doses of vancomycin. All patients initially received vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 1 , January 2000 , pp. 48 - 50
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Shay, DK, Maloney SA Montecalvo, M, Banerjee, S, Wormser, GP, Arduino, MJ, et al. Epidemiology and mortality risk of vancomycin-resistant ente-rococcal bloodstream infections. J Infect Dis 1995;172:993–1000.Google Scholar
2.Rubin, LG, Tucci, V, Cercenado, E, Eliopoulos, G, Isenberg, HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700–705.Google Scholar
3.Shay, DK, Goldmann, DA, Jarvis, WR, Reducing the spread of antimicrobial-resistant organisms: control of vancomycin-resistant enterococci. Pediatr Clin North Am 1995;42:703–716.Google Scholar
4.Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105–113.CrossRefGoogle Scholar
5.Smith, TL, Pearson, ML, Wilcox, KR, Cruz, C, Lancaster, MV, Robinson-Dunn, B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl JMed 1999;340:493–501.Google Scholar
6.Sinkowitz, RL, Keyserling, H, Walker, TJ, Holland, J, Jarvis, WR. Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995. Pediatr Infect Dis J 1997;16:485–489.Google Scholar
7.Ena, J, Dick, RW, Jones, RN, Wenzel, RP. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA 1993;269:598–602.Google Scholar
8.Evans, ME, Kortas, KJ. Vancomycin use in a university medical center: comparison with Hospital Infection Control Practices Advisory Committee guidelines. Infect Control Hosp Epidemiol 1996;17:356–359.Google Scholar
9.Johnson, SV, Hoey, LL, Vance-Bryan, K. Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention. Pharmacotherapy 1995;15:579–585.Google Scholar
10.Watanakunakorn, C. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18:767–769.Google Scholar